VST Bio

San Diego, United States

VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.

$16.1M raised

Mar 2026

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VST Bio raised?

VST Bio has raised $16.1M in total funding. The most recent round was Series A. The last funding was announced in March 2026.

Who are VST Bio's investors?

VST Bio's investors include Coefficient Giving.

Where is VST Bio headquartered?

VST Bio is headquartered in San Diego, United States.

What does VST Bio do?

VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.

What stage is VST Bio at?

VST Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 17, 2026.

MLA

"VST Bio — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/vst-bio. Accessed July 3, 2026.

APA

VCBacked. (2026). VST Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/vst-bio

Wikipedia (cite web)

{{cite web |title=VST Bio — Funding & Investors |url=https://www.vcbacked.co/company/vst-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 17, 2026.